Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Shah Capital Nominates Two Independent Director Candidates For Novavax

Author: Benzinga Newsdesk | April 15, 2024 06:03am

Shah Capital, which owns approximately 6.7% of the outstanding common stock of Novavax, recommends the appointment to Novavax board of two new independent directors: Suresh Katta and Venkat Peri. Shah Capital which owns 6.7% of Novavax, in a letter to the board says that the low share price reflects the board and management's failure to capitalize on Novavax's many significant competitive advantages and TAM opportunities. The letter highlights that the underperformance is self-inflicted and is the result of reactive leadership and outdated and old-fashioned marketing.

Posted In: NVAX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist